- Home
- TRUG vs PPBT Comparison
TRUG vs PPBT Comparison
Compare TRUG & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUG
- PPBT
- Stock Information
- Founded
- TRUG 1983
- PPBT 2010
- Country
- TRUG United States
- PPBT Israel
- Employees
- TRUG N/A
- PPBT N/A
- Industry
- TRUG
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- TRUG
- PPBT Health Care
- Exchange
- TRUG NYSE
- PPBT Nasdaq
- Market Cap
- TRUG 7.0M
- PPBT 6.2M
- IPO Year
- TRUG N/A
- PPBT N/A
- Fundamental
- Price
- TRUG $5.15
- PPBT $2.40
- Analyst Decision
- TRUG Strong Buy
- PPBT Strong Buy
- Analyst Count
- TRUG 1
- PPBT 1
- Target Price
- TRUG $100.00
- PPBT $33.00
- AVG Volume (30 Days)
- TRUG 74.4K
- PPBT 20.0K
- Earning Date
- TRUG 08-13-2025
- PPBT 08-15-2025
- Dividend Yield
- TRUG N/A
- PPBT N/A
- EPS Growth
- TRUG N/A
- PPBT N/A
- EPS
- TRUG N/A
- PPBT N/A
- Revenue
- TRUG $22,236,072.00
- PPBT N/A
- Revenue This Year
- TRUG $9.66
- PPBT N/A
- Revenue Next Year
- TRUG $48.94
- PPBT N/A
- P/E Ratio
- TRUG N/A
- PPBT N/A
- Revenue Growth
- TRUG 8.40
- PPBT N/A
- 52 Week Low
- TRUG $5.05
- PPBT $2.00
- 52 Week High
- TRUG $73.50
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- TRUG 29.52
- PPBT 47.27
- Support Level
- TRUG $5.05
- PPBT $2.35
- Resistance Level
- TRUG $6.33
- PPBT $2.58
- Average True Range (ATR)
- TRUG 0.62
- PPBT 0.12
- MACD
- TRUG 0.06
- PPBT 0.01
- Stochastic Oscillator
- TRUG 5.71
- PPBT 43.75
About TRUG TRUGOLF HOLDINGS INC
TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games (including Links, a sports game for PC), hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.